Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma
The diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the bi...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2024-03-01
|
Series: | Diagnostics |
Subjects: | |
Online Access: | https://www.mdpi.com/2075-4418/14/6/640 |
_version_ | 1827306566738509824 |
---|---|
author | Khin-Than Win Yen-Chuan Hsieh Hung-Chang Wu Shih-Sung Chuang |
author_facet | Khin-Than Win Yen-Chuan Hsieh Hung-Chang Wu Shih-Sung Chuang |
author_sort | Khin-Than Win |
collection | DOAJ |
description | The diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the biologic basis or clinical significance of such co-expression is unclear, this rare event may pose a significant diagnostic challenge. Here, we report a case of a 63-year-old male presenting with bilateral cervical lymphadenopathy and lymphocytosis. Histologically, the nodal tumor was largely diffuse with neoplastic small atypical lymphocytes co-expressing CD5, CD10, and CD20, but not CD23 or cyclin D1. The leukemic cells in the peripheral blood exhibited hairy projections. Taking together the marked splenomegaly, involvement of lymph nodes, bone marrow, and peripheral blood, a final diagnosis of splenic marginal zone lymphoma (SMZL) was reached. The patient was alive with partial response for 10 months after immunochemotherapy. The dual expression of CD5 and CD10 is extremely unusual for low-grade BCL and may lead to an erroneous diagnosis. Integrating the findings into peripheral blood smear tests, flow cytometry, histopathology, imaging, and clinical features is mandatory to exclude other lymphoma types and to reach a correct diagnosis, particularly for a case with nodal presentation. |
first_indexed | 2024-04-24T18:23:38Z |
format | Article |
id | doaj.art-8afc131a772c4a29a076babc40b54b39 |
institution | Directory Open Access Journal |
issn | 2075-4418 |
language | English |
last_indexed | 2024-04-24T18:23:38Z |
publishDate | 2024-03-01 |
publisher | MDPI AG |
record_format | Article |
series | Diagnostics |
spelling | doaj.art-8afc131a772c4a29a076babc40b54b392024-03-27T13:33:24ZengMDPI AGDiagnostics2075-44182024-03-0114664010.3390/diagnostics14060640Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone LymphomaKhin-Than Win0Yen-Chuan Hsieh1Hung-Chang Wu2Shih-Sung Chuang3Department of Pathology, Chi-Mei Medical Center, Tainan 710, TaiwanDepartment of Clinical Pathology, Chi-Mei Medical Center, Tainan 710, TaiwanDivision of Hemato-Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Tainan 710, TaiwanDepartment of Pathology, Chi-Mei Medical Center, Tainan 710, TaiwanThe diagnosis of lymphoma is based on histopathological and immunophenotypical features. CD5 and CD10 are traditionally considered a T-cell antigen and a germinal center B-cell antigen, respectively. It is very unusual for a low-grade B-cell lymphoma (BCL) to co-express CD5 and CD10. Although the biologic basis or clinical significance of such co-expression is unclear, this rare event may pose a significant diagnostic challenge. Here, we report a case of a 63-year-old male presenting with bilateral cervical lymphadenopathy and lymphocytosis. Histologically, the nodal tumor was largely diffuse with neoplastic small atypical lymphocytes co-expressing CD5, CD10, and CD20, but not CD23 or cyclin D1. The leukemic cells in the peripheral blood exhibited hairy projections. Taking together the marked splenomegaly, involvement of lymph nodes, bone marrow, and peripheral blood, a final diagnosis of splenic marginal zone lymphoma (SMZL) was reached. The patient was alive with partial response for 10 months after immunochemotherapy. The dual expression of CD5 and CD10 is extremely unusual for low-grade BCL and may lead to an erroneous diagnosis. Integrating the findings into peripheral blood smear tests, flow cytometry, histopathology, imaging, and clinical features is mandatory to exclude other lymphoma types and to reach a correct diagnosis, particularly for a case with nodal presentation.https://www.mdpi.com/2075-4418/14/6/640CD5CD10marginal zone lymphomaphenotypic aberrancysplenic marginal zone lymphomavillous lymphocyte |
spellingShingle | Khin-Than Win Yen-Chuan Hsieh Hung-Chang Wu Shih-Sung Chuang Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma Diagnostics CD5 CD10 marginal zone lymphoma phenotypic aberrancy splenic marginal zone lymphoma villous lymphocyte |
title | Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma |
title_full | Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma |
title_fullStr | Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma |
title_full_unstemmed | Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma |
title_short | Nodal Low-Grade B-Cell Lymphoma Co-Expressing CD5 and CD10 but Not CD23, IRTA1, or Cyclin D1: The Diagnostic Challenge of a Splenic Marginal Zone Lymphoma |
title_sort | nodal low grade b cell lymphoma co expressing cd5 and cd10 but not cd23 irta1 or cyclin d1 the diagnostic challenge of a splenic marginal zone lymphoma |
topic | CD5 CD10 marginal zone lymphoma phenotypic aberrancy splenic marginal zone lymphoma villous lymphocyte |
url | https://www.mdpi.com/2075-4418/14/6/640 |
work_keys_str_mv | AT khinthanwin nodallowgradebcelllymphomacoexpressingcd5andcd10butnotcd23irta1orcyclind1thediagnosticchallengeofasplenicmarginalzonelymphoma AT yenchuanhsieh nodallowgradebcelllymphomacoexpressingcd5andcd10butnotcd23irta1orcyclind1thediagnosticchallengeofasplenicmarginalzonelymphoma AT hungchangwu nodallowgradebcelllymphomacoexpressingcd5andcd10butnotcd23irta1orcyclind1thediagnosticchallengeofasplenicmarginalzonelymphoma AT shihsungchuang nodallowgradebcelllymphomacoexpressingcd5andcd10butnotcd23irta1orcyclind1thediagnosticchallengeofasplenicmarginalzonelymphoma |